Difference between revisions of "Myocardial ischaemia"
(Imported from Wikispaces) |
|||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
| − | |||
| − | <span style="display: block; font-size: | + | <span style="display: block; text-align: center;"><span style="color: #9000ff; font-family: Arial,Helvetica,sans-serif; font-size: 150%;">'''<span style="display: block; text-align: center;">MYOCARDIAL ISCHAEMIA</span>'''</span></span> |
| − | [[File: | + | <span style="display: block; font-size: 26px; text-align: center;">[[Home|HOME]] [[Index_page|INDEX]] [[Search_Database|SEARCH DATABASE]] [[What_is_a_CAT?|WHAT IS A CAT?]][[What_can_I_do?|WHAT CAN YOU DO?]] [[Introduction|INTRODUCTION]] [[What_is_hyperbaric_medicine?|HBO EXPLAINED]]</span> |
| + | |||
| + | [[File:Sumhorsa.gif|center|Sumhorsa.gif]] | ||
| − | |||
<span style="display: block; text-align: center;"><span style="font-family: Arial,Helvetica,sans-serif; font-size: 140%;">HBO for the treatment or identification of ischaemic heart muscle</span></span> | <span style="display: block; text-align: center;"><span style="font-family: Arial,Helvetica,sans-serif; font-size: 140%;">HBO for the treatment or identification of ischaemic heart muscle</span></span> | ||
| − | [[File: | + | [[File:Sumhorsa.gif|center|Sumhorsa.gif]] |
| − | + | <span style="display: block; text-align: center;"><span style="font-family: Arial,Helvetica,sans-serif; font-size: 150%;">Last searched November 2017. Next search June 2021</span></span> | |
| − | + | ||
| − | </span> | + | {| class="Table" style="border:undefined" |
| − | {| | ||
| − | |||
|- | |- | ||
| − | | <span style'''"font-size: | + | | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Author 1</span></span>'''</span></p> |
| + | | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Author 2</span></span>'''</span></p> | ||
| + | | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Author 3</span></span>'''</span></p> | ||
| + | | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Title</span></span>'''</span></p> | ||
| + | | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Citation</span></span>'''</span></p> | ||
| + | | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Search term 1</span></span>'''</span></p> | ||
| + | | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Search term 2</span></span>'''</span></p> | ||
| + | | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:12.0pt"><span style="font-family:">Search term 3</span></span>'''</span></p> | ||
| + | | <p align="center" style="margin-bottom:.0001pt; text-align:center; padding:.75pt .75pt .75pt .75pt"><span style="line-height:normal">'''<span style="font-size:14.5pt"><span style="font-family:">Review date</span></span>'''</span></p> | ||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Cameron|<span style="color:blue">Cameron AJ</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Gibb BH</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Ledingham I</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">A controlled clinical trial of hyperbaric oxygen in the treatment of acute myocardial infarction.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">In: Hyperbaric Oxygenation: Proceedings of the Second International Congress. Ledingham I ed, London ES Livingstone 1965:277</span></span></span> | ||
| + | |||
| + | | style="padding:.75pt .75pt .75pt .75pt" | | ||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial Infarction</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">cardiogenic shock</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Thurston|<span style="color:blue">Thurston GJ</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Greenwood TW</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Bending MR</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Quarterly Journal of Medicine 1973; XLII:751-770.</span></span></span> | ||
| + | |||
| + | | style="padding:.75pt .75pt .75pt .75pt" | | ||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial infarction</span></span></span> | ||
| + | |||
| + | | style="padding:.75pt .75pt .75pt .75pt" | | ||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Swift|<span style="color:blue">Swift PC</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Turner JH</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Oxer HF</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">American Heart Journal 1992; 124:1151-1158.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Mycardial Infarction</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial Contraction</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Thallium Radio-isotopes</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Shandling|<span style="color:blue">Shandling AH</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Ellestad MH</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Hart GB</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Hyperbaric oxygen and thrombolysis in myocardial infarction: The "HOT MI" pilot study.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">American Heart Journal 1997; 134:544-550.</span></span></span> | ||
| + | |||
| + | | style="padding:.75pt .75pt .75pt .75pt" | | ||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial infarction</span></span></span> | ||
| + | |||
| + | | style="padding:.75pt .75pt .75pt .75pt" | | ||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:13.0pt"><span style="font-family:">01/11/2020</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Stavitsky|<span style="color:blue">Stavitsky Y</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Shandling AH</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Ellestad MH</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Coronary Care Cardiology 1998; 90:131-136.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial Infarction</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Thrombolytic Therapy</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Tissue Plasminogen Activator</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Dekleva|<span style="color:blue">Dekleva MN</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Ostojic M</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Vujnovic D</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">In: Sitinen SA, Leinio M, eds. Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS), Helsinki, Finland 1995:9-13</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial infarction</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Thrombolytic therapy</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Tissue plasminogen activator</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Sharifi|<span style="color:blue">Sharifi M</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Fares W</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Abdel-Karim I</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Usefulness of Hyperbaric Oxygen Therapy to Inhibit Restenosis After Percutaneous Coronary Intervention for Acute Myocardial Infarction or Unstable Angina Pectoris</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Am J Cardiol 2004;93:1533-1535</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial infarction</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Coronary stent</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Re-stenosis</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Dekleva|<span style="color:blue">Dekleva M</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Neskovic A</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Vlahovic A</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Am Heart J 2004; 148(4):589</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial infarction</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Echocardiography</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Thrombolytic therapy</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Vlahovic|<span style="color:blue">Vlahovic A</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Neskovic AN</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Dekleva M</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">American Heart Journal 2004; 148:J1-J7.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial infarction</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Echocardiography</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Thrombolytic therapy</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Alex|<span style="color:blue">Alex J</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Laden G</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Cale A,</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: A prospective randomised double-blind trial.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Journal of Thoracic and Cardiovascular Surgery 2005;130(6):1623-30.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Cardiac bypass</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Neuropsychiatric</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Inflammatory markers</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Yogaratnam|<span style="color:blue">Yogaratnam JZ</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Laden G</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Madden LA</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Hyperbaric oxygen preconditioning promotes cardioprotection following ischemic reperfusion injury by improving myocardial function, limiting necrosis and enhancing the induction of Hsp72.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Undersea and Hyperbaric Medicine 2007; 34(4):301-302</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Cardiac bypass</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Ischaemia reperfusion</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial function</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Yogaratnam|<span style="color:blue">Yogaratnam J</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Laden G</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Guvendik L</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Cardiovascular Revascularization Medicine: Including Molecular Interventions 2010;11(1):8-19</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Cardiac bypass</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Ischaemia reperfusion</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial functin</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span style | + | | |
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Yogaratnam|<span style="color:blue">Yogaratnam J</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Laden G</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Guvendik L</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">The effects of hyperbaric oxygen preconditioning on</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">myocardial biomarkers of cardioprotection in patients having coronary</span></span></span> | ||
| + | |||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">artery bypass graft surgery</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Undersea and Hyperbaric Medicine 2011;38(3):175-185</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Cardiac bypass</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Ischaemia reperfusion</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial protection</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|- | |- | ||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Bennett1|<span style="color:blue">Bennett M</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Lehm JP</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Jepson N</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Hyperbaric oxygen for acute coronary syndrome</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Cochrane database of systematic reviews 2011</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Acute coronary syndrome</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial infarction</span></span></span> | ||
| + | |||
| + | | style="padding:.75pt .75pt .75pt .75pt" | | ||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
| + | |- | ||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">[[Yang|<span style="color:blue">Yang L</span>]]</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Dong H</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Chen M</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial.</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Journal of Cardiothoracic and Vascular Anesthesia 2011;25(6):908-916</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Cardiac bypass</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Ischaemia reperfusion</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:12.0pt"><span style="font-family:">Myocardial function</span></span></span> | ||
| + | |||
| + | | | ||
| + | <span style="line-height:normal"><span style="font-size:10.5pt"><span style="font-family:">01/06/2021</span></span></span> | ||
| + | |||
|} | |} | ||
| − | <span style="display: block; text-align: center;"><span style="font-size: 26px;">[[ | + | <span style="display: block; text-align: center;"><span style="font-size: 26px;">[[Home|HOME]] [[Index_page|INDEX]] [[Search_Database|SEARCH DATABASE]] [[What_is_a_CAT?|WHAT IS A CAT?]]</span></span><span style="display: block; text-align: center;"><span style="font-size: 26px;">[[What_can_I_do?|WHAT CAN YOU DO?]] [[Introduction|INTRODUCTION]] [[What_is_hyperbaric_medicine?|HBO EXPLAINED]]</span></span> |
| + | |||
| + | | ||
| − | + | [[File:Sumhorsa.gif|center|Sumhorsa.gif]] | |
| − | + | | |
| − | </span> | + | <span style="display: block; text-align: center;"><span style="font-size: 180%;">[[Acute_ischaemia|BACK]]</span></span> |
| − | |||
| − | |||
[[Category:Acute ischaemia]] | [[Category:Acute ischaemia]] | ||
Revision as of 20:38, 5 May 2019
MYOCARDIAL ISCHAEMIA
HOME INDEX SEARCH DATABASE WHAT IS A CAT?WHAT CAN YOU DO? INTRODUCTION HBO EXPLAINED
HBO for the treatment or identification of ischaemic heart muscle
Last searched November 2017. Next search June 2021
Author 1 |
Author 2 |
Author 3 |
Title |
Citation |
Search term 1 |
Search term 2 |
Search term 3 |
Review date |
|
Gibb BH |
Ledingham I |
A controlled clinical trial of hyperbaric oxygen in the treatment of acute myocardial infarction. |
In: Hyperbaric Oxygenation: Proceedings of the Second International Congress. Ledingham I ed, London ES Livingstone 1965:277 |
Myocardial Infarction |
cardiogenic shock |
01/06/2021 | ||
|
Greenwood TW |
Bending MR |
A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. |
Quarterly Journal of Medicine 1973; XLII:751-770. |
Myocardial infarction |
01/06/2021 | |||
|
Turner JH |
Oxer HF |
Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. |
American Heart Journal 1992; 124:1151-1158. |
Mycardial Infarction |
Myocardial Contraction |
Thallium Radio-isotopes |
01/06/2021 | |
|
Ellestad MH |
Hart GB |
Hyperbaric oxygen and thrombolysis in myocardial infarction: The "HOT MI" pilot study. |
American Heart Journal 1997; 134:544-550. |
Myocardial infarction |
01/11/2020 | |||
|
Shandling AH |
Ellestad MH |
Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. |
Coronary Care Cardiology 1998; 90:131-136. |
Myocardial Infarction |
Thrombolytic Therapy |
Tissue Plasminogen Activator |
01/06/2021 | |
|
Ostojic M |
Vujnovic D |
Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. |
In: Sitinen SA, Leinio M, eds. Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS), Helsinki, Finland 1995:9-13 |
Myocardial infarction |
Thrombolytic therapy |
Tissue plasminogen activator |
01/06/2021 | |
|
Fares W |
Abdel-Karim I |
Usefulness of Hyperbaric Oxygen Therapy to Inhibit Restenosis After Percutaneous Coronary Intervention for Acute Myocardial Infarction or Unstable Angina Pectoris |
Am J Cardiol 2004;93:1533-1535 |
Myocardial infarction |
Coronary stent |
Re-stenosis |
01/06/2021 | |
|
Neskovic A |
Vlahovic A |
Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction |
Am Heart J 2004; 148(4):589 |
Myocardial infarction |
Echocardiography |
Thrombolytic therapy |
01/06/2021 | |
|
Neskovic AN |
Dekleva M |
Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. |
American Heart Journal 2004; 148:J1-J7. |
Myocardial infarction |
Echocardiography |
Thrombolytic therapy |
01/06/2021 | |
|
Laden G |
Cale A, |
Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: A prospective randomised double-blind trial. |
Journal of Thoracic and Cardiovascular Surgery 2005;130(6):1623-30. |
Cardiac bypass |
Neuropsychiatric |
Inflammatory markers |
01/06/2021 | |
|
Laden G |
Madden LA |
Hyperbaric oxygen preconditioning promotes cardioprotection following ischemic reperfusion injury by improving myocardial function, limiting necrosis and enhancing the induction of Hsp72. |
Undersea and Hyperbaric Medicine 2007; 34(4):301-302 |
Cardiac bypass |
Ischaemia reperfusion |
Myocardial function |
01/06/2021 | |
|
Laden G |
Guvendik L |
Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery. |
Cardiovascular Revascularization Medicine: Including Molecular Interventions 2010;11(1):8-19 |
Cardiac bypass |
Ischaemia reperfusion |
Myocardial functin |
01/06/2021 | |
|
Laden G |
Guvendik L |
The effects of hyperbaric oxygen preconditioning on myocardial biomarkers of cardioprotection in patients having coronary artery bypass graft surgery |
Undersea and Hyperbaric Medicine 2011;38(3):175-185 |
Cardiac bypass |
Ischaemia reperfusion |
Myocardial protection |
01/06/2021 | |
|
Lehm JP |
Jepson N |
Hyperbaric oxygen for acute coronary syndrome |
Cochrane database of systematic reviews 2011 |
Acute coronary syndrome |
Myocardial infarction |
01/06/2021 | ||
|
Dong H |
Chen M |
Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial. |
Journal of Cardiothoracic and Vascular Anesthesia 2011;25(6):908-916 |
Cardiac bypass |
Ischaemia reperfusion |
Myocardial function |
01/06/2021 |
HOME INDEX SEARCH DATABASE WHAT IS A CAT?WHAT CAN YOU DO? INTRODUCTION HBO EXPLAINED
